
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
Highlights
The global Extra Corporeal Membrane Oxygenation (ECMO) System market was valued at US$ 298.1 million in 2022 and is anticipated to reach US$ 362.2 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global extracorporeal membrane oxygenation (ECMO) system market is dominated by North America (41%) and Europe (34%). The market is growing due to improved patient safety and awareness among the doctors and patients. The Asian market is growing due to increasing adoption rate of ECMO machine in hospitals, success rate of ECMO & government initiatives, and growing awareness towards ECMO.
This market is segmented and forecast on the basis of modality, application and geography. The modality comprises of Veno Artrial (VA), Veno Venous (VV), the Veno Venous (VV) contributed to 61.82% of global market of ECMO system industry.
For China market, the industry is developing rapidly. The main players are Medtronic, Maquet, Sorin, Terumo and Xenios. Medtronic and Maquet enjoy more than 50% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Extra Corporeal Membrane Oxygenation (ECMO) System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extra Corporeal Membrane Oxygenation (ECMO) System.
The Extra Corporeal Membrane Oxygenation (ECMO) System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Extra Corporeal Membrane Oxygenation (ECMO) System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Extra Corporeal Membrane Oxygenation (ECMO) System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Nipro
Alung Technologies Inc
Terumo Corporation
Microport Scientific Corporation
Livanova
Segment by Type
Veno-arterial Mode (VA)
Veno-venous Mode (VV)
Artery-vein Mode (AV)
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Extra Corporeal Membrane Oxygenation (ECMO) System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Veno-arterial Mode (VA)
1.2.3 Veno-venous Mode (VV)
1.2.4 Artery-vein Mode (AV)
1.3 Market by Application
1.3.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Perspective (2018-2029)
2.2 Extra Corporeal Membrane Oxygenation (ECMO) System Growth Trends by Region
2.2.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Extra Corporeal Membrane Oxygenation (ECMO) System Historic Market Size by Region (2018-2023)
2.2.3 Extra Corporeal Membrane Oxygenation (ECMO) System Forecasted Market Size by Region (2024-2029)
2.3 Extra Corporeal Membrane Oxygenation (ECMO) System Market Dynamics
2.3.1 Extra Corporeal Membrane Oxygenation (ECMO) System Industry Trends
2.3.2 Extra Corporeal Membrane Oxygenation (ECMO) System Market Drivers
2.3.3 Extra Corporeal Membrane Oxygenation (ECMO) System Market Challenges
2.3.4 Extra Corporeal Membrane Oxygenation (ECMO) System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extra Corporeal Membrane Oxygenation (ECMO) System Players by Revenue
3.1.1 Global Top Extra Corporeal Membrane Oxygenation (ECMO) System Players by Revenue (2018-2023)
3.1.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Revenue Market Share by Players (2018-2023)
3.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Extra Corporeal Membrane Oxygenation (ECMO) System Revenue
3.4 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Concentration Ratio
3.4.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extra Corporeal Membrane Oxygenation (ECMO) System Revenue in 2022
3.5 Extra Corporeal Membrane Oxygenation (ECMO) System Key Players Head office and Area Served
3.6 Key Players Extra Corporeal Membrane Oxygenation (ECMO) System Product Solution and Service
3.7 Date of Enter into Extra Corporeal Membrane Oxygenation (ECMO) System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Extra Corporeal Membrane Oxygenation (ECMO) System Breakdown Data by Type
4.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Historic Market Size by Type (2018-2023)
4.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Forecasted Market Size by Type (2024-2029)
5 Extra Corporeal Membrane Oxygenation (ECMO) System Breakdown Data by Application
5.1 Global Extra Corporeal Membrane Oxygenation (ECMO) System Historic Market Size by Application (2018-2023)
5.2 Global Extra Corporeal Membrane Oxygenation (ECMO) System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2018-2029)
6.2 North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2018-2023)
6.4 North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2018-2029)
7.2 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2018-2023)
7.4 Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2018-2029)
8.2 Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Region (2018-2023)
8.4 Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2018-2029)
9.2 Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2018-2023)
9.4 Latin America Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Size (2018-2029)
10.2 Middle East & Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2018-2023)
10.4 Middle East & Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.1.4 Medtronic Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Nipro
11.2.1 Nipro Company Detail
11.2.2 Nipro Business Overview
11.2.3 Nipro Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.2.4 Nipro Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.2.5 Nipro Recent Development
11.3 Alung Technologies Inc
11.3.1 Alung Technologies Inc Company Detail
11.3.2 Alung Technologies Inc Business Overview
11.3.3 Alung Technologies Inc Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.3.4 Alung Technologies Inc Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.3.5 Alung Technologies Inc Recent Development
11.4 Terumo Corporation
11.4.1 Terumo Corporation Company Detail
11.4.2 Terumo Corporation Business Overview
11.4.3 Terumo Corporation Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.4.4 Terumo Corporation Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.4.5 Terumo Corporation Recent Development
11.5 Microport Scientific Corporation
11.5.1 Microport Scientific Corporation Company Detail
11.5.2 Microport Scientific Corporation Business Overview
11.5.3 Microport Scientific Corporation Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.5.4 Microport Scientific Corporation Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.5.5 Microport Scientific Corporation Recent Development
11.6 Livanova
11.6.1 Livanova Company Detail
11.6.2 Livanova Business Overview
11.6.3 Livanova Extra Corporeal Membrane Oxygenation (ECMO) System Introduction
11.6.4 Livanova Revenue in Extra Corporeal Membrane Oxygenation (ECMO) System Business (2018-2023)
11.6.5 Livanova Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Medtronic
Nipro
Alung Technologies Inc
Terumo Corporation
Microport Scientific Corporation
Livanova
Ìý
Ìý
*If Applicable.
